Published in Clin Infect Dis on May 26, 2005
Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis (2016) 1.58
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol (2012) 1.07
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. J Clin Microbiol (2010) 1.03
Invasive fungal infections in solid organ transplant recipients. Future Microbiol (2012) 1.01
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. Eur J Clin Microbiol Infect Dis (2011) 0.98
Epidemiology of invasive mold infections in lung transplant recipients. Am J Transplant (2014) 0.86
Fungal infections in renal transplant patients. J Clin Med Res (2015) 0.85
A risk prediction score for invasive mold disease in patients with hematological malignancies. PLoS One (2013) 0.82
Mycological Microscopic and Culture Examination of 400 Bronchoalveolar Lavage (BAL) Samples. Iran J Public Health (2012) 0.82
Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study. Transpl Infect Dis (2010) 0.80
Infections after orthotopic liver transplantation. J Clin Exp Hepatol (2014) 0.79
Invasive mold infections in solid organ transplant recipients. Scientifica (Cairo) (2014) 0.79
Host genetics of invasive Aspergillus and Candida infections. Semin Immunopathol (2014) 0.77
Invasive aspergillosis in a renal transplant recipient successfully treated with interferon-gamma. Case Rep Transplant (2012) 0.76
Fatal Case of Probable Invasive Aspergillosis after Five Years of Heart Transplant: A Case Report and Review of the Literature. Case Rep Infect Dis (2015) 0.75
Prognosis of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study. Transplant Direct (2016) 0.75
Invasive pulmonary aspergillosis in a haematopoietic stem cell transplant recipient with sickle cell disease: a successful treatment. Mediterr J Hematol Infect Dis (2015) 0.75
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother (2007) 3.54
A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (2003) 3.17
Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol (2001) 2.87
Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med (1987) 2.78
A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. Am J Trop Med Hyg (2001) 2.73
Structural analysis of a set of proteins resulting from a bacterial genomics project. Proteins (2005) 2.59
Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol (2008) 2.57
Biochemical and immunological characterization of the surface proteins of Borrelia burgdorferi. Infect Immun (1989) 2.56
[CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection]. Med Clin (Barc) (1994) 2.56
Age-related changes in human ciliary muscle and lens: a magnetic resonance imaging study. Invest Ophthalmol Vis Sci (1999) 2.52
Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother (2004) 2.51
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
Long-standing Morel-Lavallée lesions of the trochanteric region and proximal thigh: MRI features in five patients. AJR Am J Roentgenol (2004) 2.42
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am J Med (1996) 2.36
Clinical spectrum of urinary tract infections due on nontyphoidal Salmonella species. Clin Infect Dis (1996) 2.33
A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature (1988) 2.26
Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med (1988) 2.24
Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J Clin Microbiol (2001) 2.21
Gastrointestinal bezoars. Br J Surg (1994) 2.21
Failure of mebendazole treatment in Giardia lamblia infection. Trans R Soc Trop Med Hyg (1990) 2.16
Transient tyrosinemia of the newborn: dietary and clinical aspects. Pediatrics (1967) 2.15
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother (2013) 2.14
Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates. Am J Transplant (2015) 2.08
[Endocarditis caused by non-diphtheriae Corynebacterium. Presentation of 12 cases and review]. Enferm Infecc Microbiol Clin (1993) 2.07
Severe traumatic head injury: prognostic value of brain stem injuries detected at MRI. AJNR Am J Neuroradiol (2012) 2.06
[Splenic abscesses caused by Mycobacterium tuberculosis in AIDS]. Enferm Infecc Microbiol Clin (1994) 2.03
Toxoplasmosis in cord blood transplantation recipients. Transpl Infect Dis (2012) 2.03
Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: a new phenomenon with clinical implications. Bone Marrow Transplant (2010) 2.02
Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study. Clin Microbiol Infect (2014) 2.02
Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms. J Clin Microbiol (1985) 2.01
Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J Virol (2006) 2.00
Visceral leishmaniasis in immunocompromised hosts. Am J Med (1987) 1.99
Pregnanediols and neonatal hyperbilirubinemia. Am J Dis Child (1966) 1.88
Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J Antimicrob Chemother (2002) 1.87
Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature (1987) 1.85
Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem (1986) 1.82
Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis (1997) 1.77
Alendronate for treatment of renal transplant patients with osteoporosis. Transplant Proc (2003) 1.75
Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol (1992) 1.74
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70
Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis (1995) 1.67
In vivo nuclear magnetic resonance studies of glycolytic kinetics in Lactococcus lactis. Biotechnol Bioeng (1999) 1.67
Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med (1994) 1.66
Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax (2001) 1.66
Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother (2005) 1.66
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother (2007) 1.66
EUCAST technical note on anidulafungin. Clin Microbiol Infect (2011) 1.63
Fluid flow induced by nonuniform ac electric fields in electrolytes on microelectrodes. III. Observation of streamlines and numerical simulation. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.62
Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect (2014) 1.61
In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother (2000) 1.61
The submarine volcano eruption at the island of El Hierro: physical-chemical perturbation and biological response. Sci Rep (2012) 1.60
Evaluation of the upgraded amplified Mycobacterium tuberculosis direct test (gen-probe) for direct detection of Mycobacterium tuberculosis in respiratory and non-respiratory specimens. Diagn Microbiol Infect Dis (2001) 1.60
Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun (2001) 1.60
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother (2011) 1.59
Cacao domestication I: the origin of the cacao cultivated by the Mayas. Heredity (Edinb) (2002) 1.59
Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med (1992) 1.58
Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation. Clin Infect Dis (1998) 1.57
Urinary tract infection caused by Corynebacterium group D2: report of 82 cases and review. Rev Infect Dis (1991) 1.56
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir. AIDS (2001) 1.56
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect (2012) 1.55
Naphthalimides as anti-cancer agents: synthesis and biological activity. Curr Med Chem Anticancer Agents (2001) 1.55
Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi. J Immunol (1991) 1.55
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol (2005) 1.55
Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review. Clin Infect Dis (1992) 1.54
Differential effects of cytochalasin D and 2,3 butanedione monoxime on isometric twitch force and transmembrane action potential in isolated ventricular muscle: implications for optical measurements of cardiac repolarization. J Cardiovasc Electrophysiol (1998) 1.54
Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med (1999) 1.53
Functional analysis of the Lactococcus lactis galU and galE genes and their impact on sugar nucleotide and exopolysaccharide biosynthesis. Appl Environ Microbiol (2001) 1.52
Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology (1996) 1.52
Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol (2012) 1.51
Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection. Am J Transplant (2012) 1.51
Current understanding and management of chronic hepatosplenic suppurative brucellosis. Clin Infect Dis (2001) 1.51
Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum. J Exp Med (2000) 1.50
Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose. Antimicrob Agents Chemother (2000) 1.50
Primary structure and inhibition of protein synthesis in eukaryotic cell-free system of a novel thionin, gamma-hordothionin, from barley endosperm. Eur J Biochem (1990) 1.49
Bilateral transfemoral lower extremity transplantation: result at 1 year. Am J Transplant (2013) 1.49
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect (2012) 1.48
Accessory ossicles and sesamoid bones of the ankle and foot: imaging findings, clinical significance and differential diagnosis. Eur Radiol (2003) 1.47
A case of Hirayama disease treated with laminectomy and duraplasty without spinal fusion. Neurocirugia (Astur) (2009) 1.47
A comparative study of magnetic resonance cholangiography and direct cholangiography. Rev Esp Enferm Dig (2000) 1.47
Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi. J Immunol (1990) 1.47
Cohort study of intestinal infection with campylobacter in Mexican children. Lancet (1988) 1.46
[Soft-tissue infection caused by Aeromonas hydrophila]. Enferm Infecc Microbiol Clin (1995) 1.46
Malignant mastocytosis with circulating mast cells. Am J Hematol (1990) 1.45
A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect (2001) 1.45
Lupus vulgaris. Clinical, histopathologic, and bacteriologic study of 10 cases. J Am Acad Dermatol (1992) 1.44
Early molecular diagnosis of acute Chagas disease after transplantation with organs from Trypanosoma cruzi-infected donors. Am J Transplant (2013) 1.44